JP2019514970A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019514970A5 JP2019514970A5 JP2018558199A JP2018558199A JP2019514970A5 JP 2019514970 A5 JP2019514970 A5 JP 2019514970A5 JP 2018558199 A JP2018558199 A JP 2018558199A JP 2018558199 A JP2018558199 A JP 2018558199A JP 2019514970 A5 JP2019514970 A5 JP 2019514970A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- antimetabolite
- individual
- bladder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021172052A JP2022009327A (ja) | 2016-05-06 | 2021-10-21 | 下部尿路上皮がんを処置する方法 |
| JP2023206570A JP2024028881A (ja) | 2016-05-06 | 2023-12-07 | 下部尿路上皮がんを処置する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662333151P | 2016-05-06 | 2016-05-06 | |
| US62/333,151 | 2016-05-06 | ||
| US201762443614P | 2017-01-06 | 2017-01-06 | |
| US62/443,614 | 2017-01-06 | ||
| PCT/US2017/031445 WO2017193098A1 (en) | 2016-05-06 | 2017-05-05 | Method of treating lower tract urothelial cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021172052A Division JP2022009327A (ja) | 2016-05-06 | 2021-10-21 | 下部尿路上皮がんを処置する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019514970A JP2019514970A (ja) | 2019-06-06 |
| JP2019514970A5 true JP2019514970A5 (cg-RX-API-DMAC7.html) | 2020-06-18 |
| JP7712055B2 JP7712055B2 (ja) | 2025-07-23 |
Family
ID=60203435
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018558199A Active JP7712055B2 (ja) | 2016-05-06 | 2017-05-05 | 下部尿路上皮がんを処置する方法 |
| JP2021172052A Withdrawn JP2022009327A (ja) | 2016-05-06 | 2021-10-21 | 下部尿路上皮がんを処置する方法 |
| JP2023206570A Withdrawn JP2024028881A (ja) | 2016-05-06 | 2023-12-07 | 下部尿路上皮がんを処置する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021172052A Withdrawn JP2022009327A (ja) | 2016-05-06 | 2021-10-21 | 下部尿路上皮がんを処置する方法 |
| JP2023206570A Withdrawn JP2024028881A (ja) | 2016-05-06 | 2023-12-07 | 下部尿路上皮がんを処置する方法 |
Country Status (23)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3370768T (pt) | 2015-11-03 | 2022-04-21 | Janssen Biotech Inc | Anticorpos que se ligam especificamente ao pd-1 e seus usos |
| TWI843168B (zh) | 2016-10-11 | 2024-05-21 | 美商艾吉納斯公司 | 抗ｌａｇ－３抗體及其使用方法 |
| CA3071014A1 (en) * | 2017-07-25 | 2019-01-31 | Taris Biomedical Llc | Methods of treating tumor metastasis |
| JOP20200124A1 (ar) | 2017-11-08 | 2020-05-20 | Taris Biomedical Llc | طُرق لعلاج سرطان المثانة باستخدام جيمسيتابين وعلاج مدوامة لذلك |
| US12398209B2 (en) | 2018-01-22 | 2025-08-26 | Janssen Biotech, Inc. | Methods of treating cancers with antagonistic anti-PD-1 antibodies |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY30915A1 (es) * | 2007-02-16 | 2008-09-02 | Smithkline Beecham Corp | Método de tratamiento de canceres |
| WO2010151896A1 (en) | 2009-06-26 | 2010-12-29 | Taris Biomedical, Inc. | Solid drug tablets for implantable drug delivery devices |
| EP2512581B1 (en) | 2009-12-17 | 2021-02-17 | TARIS Biomedical LLC | Implantable device with intravesical tolerability |
| KR20130109025A (ko) * | 2010-06-02 | 2013-10-07 | 아브락시스 바이오사이언스, 엘엘씨 | 방광암의 치료 방법 |
| LT2600800T (lt) | 2010-08-05 | 2021-01-11 | Taris Biomedical Llc | Ureteralinio stento pavidalo vaisto vartojimo įtaisas ir rinkinys |
| US9107816B2 (en) | 2011-02-04 | 2015-08-18 | Taris Biomedical Llc | Implantable device for controlled dissolution and diffusion of low solubility drug |
| JP6639228B2 (ja) * | 2012-03-29 | 2020-02-05 | アルター・バイオサイエンス・コーポレーション | 新生物を治療するための方法 |
| LT2890384T (lt) * | 2012-08-31 | 2022-01-10 | Taris Biomedical Llc | Vaistų pateikimo sistemos ir kraujo vėžio gydymo būdai, apimantys oksaliplatiną |
| CA2882575C (en) | 2012-08-31 | 2020-05-26 | Dennis GIESING | Drug delivery systems and methods for treatment of prostate |
| WO2014138214A1 (en) | 2013-03-05 | 2014-09-12 | Taris Biomedical, Inc. | Drug delivery devices and methods for controlled drug release through device orifice |
| CN105209012B (zh) | 2013-03-15 | 2019-02-01 | 塔里斯生物医药公司 | 用于药物递送的药物递送装置和方法 |
| BR112015022433B1 (pt) | 2013-03-15 | 2022-06-21 | Taris Biomedical Llc | Dispositivo de liberação de droga intravesical |
| HRP20201421T1 (hr) | 2013-08-19 | 2020-12-11 | Taris Biomedical Llc | Uređaji za davanje više jedinica lijeka |
| LT3113782T (lt) * | 2014-03-06 | 2022-11-25 | Taris Biomedical Llc | Vaisto tiekimo sistemos ir būdai, skirti šlapimo pūslės vėžio gydymui gemcitabinu |
| AU2015279674B2 (en) | 2014-06-26 | 2020-07-23 | Taris Biomedical Llc | Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems |
| KR102658706B1 (ko) | 2015-04-23 | 2024-04-17 | 타리스 바이오메디컬 엘엘씨 | 약물-투과성 성분을 구비한 약물 전달 장치 및 방법 |
-
2017
- 2017-05-05 MX MX2018013432A patent/MX389296B/es unknown
- 2017-05-05 IL IL295592A patent/IL295592A/en unknown
- 2017-05-05 AU AU2017261371A patent/AU2017261371B2/en active Active
- 2017-05-05 CN CN202410626384.1A patent/CN118453872A/zh active Pending
- 2017-05-05 NZ NZ787786A patent/NZ787786A/en unknown
- 2017-05-05 SG SG10201913416PA patent/SG10201913416PA/en unknown
- 2017-05-05 JP JP2018558199A patent/JP7712055B2/ja active Active
- 2017-05-05 SM SM20230047T patent/SMT202300047T1/it unknown
- 2017-05-05 HR HRP20221544TT patent/HRP20221544T1/hr unknown
- 2017-05-05 CN CN201780040391.1A patent/CN109475571A/zh active Pending
- 2017-05-05 NZ NZ787824A patent/NZ787824A/en unknown
- 2017-05-05 ES ES17793523T patent/ES2940227T3/es active Active
- 2017-05-05 WO PCT/US2017/031445 patent/WO2017193098A1/en not_active Ceased
- 2017-05-05 HU HUE17793523A patent/HUE060965T2/hu unknown
- 2017-05-05 FI FIEP17793523.6T patent/FI3452053T3/fi active
- 2017-05-05 SG SG11201809838VA patent/SG11201809838VA/en unknown
- 2017-05-05 RU RU2022100624A patent/RU2022100624A/ru unknown
- 2017-05-05 IL IL262746A patent/IL262746B/en unknown
- 2017-05-05 SI SI201731301T patent/SI3452053T1/sl unknown
- 2017-05-05 NZ NZ748252A patent/NZ748252A/en unknown
- 2017-05-05 CA CA3023274A patent/CA3023274A1/en active Pending
- 2017-05-05 KR KR1020187035297A patent/KR102435709B1/ko active Active
- 2017-05-05 PL PL17793523.6T patent/PL3452053T3/pl unknown
- 2017-05-05 RU RU2018142908A patent/RU2764747C2/ru active
- 2017-05-05 RS RS20230163A patent/RS64032B1/sr unknown
- 2017-05-05 LT LTEPPCT/US2017/031445T patent/LT3452053T/lt unknown
- 2017-05-05 EP EP17793523.6A patent/EP3452053B1/en active Active
- 2017-05-05 EP EP22212024.8A patent/EP4209221A1/en active Pending
- 2017-05-05 PT PT177935236T patent/PT3452053T/pt unknown
- 2017-05-05 US US16/099,179 patent/US20190388338A1/en active Pending
- 2017-05-05 KR KR1020227028547A patent/KR20220123317A/ko not_active Ceased
-
2018
- 2018-11-01 MX MX2021013461A patent/MX2021013461A/es unknown
-
2021
- 2021-10-21 JP JP2021172052A patent/JP2022009327A/ja not_active Withdrawn
-
2023
- 2023-12-07 JP JP2023206570A patent/JP2024028881A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lee et al. | Immune checkpoint inhibitors in 10 years: contribution of basic research and clinical application in cancer immunotherapy | |
| JP2019514970A5 (cg-RX-API-DMAC7.html) | ||
| US10076528B2 (en) | System and method for diagnosis and treatment | |
| Antonia et al. | Immuno-oncology combinations: a review of clinical experience and future prospects | |
| AU2013329083C1 (en) | Enhancement of the immune response | |
| JP2019522657A5 (cg-RX-API-DMAC7.html) | ||
| RU2022100624A (ru) | Способ лечения рака уротелия нижних путей | |
| BR112020008537A2 (pt) | inibidores duplos de vias da tim-3 e da pd-1 | |
| Denlinger et al. | A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers | |
| Hoag et al. | Association of cetuximab with adverse pulmonary events in cancer patients: a comprehensive review | |
| Coloma et al. | High incidence of cetuximab-related infusion reactions in head and neck patients | |
| CN101612141B (zh) | 丁丙诺啡贴剂 | |
| CN119923256A (zh) | 包含大麻素的连续递送系统及其医药用途 | |
| Komarnitsky et al. | P1. 04-006 rovalpituzumab tesirine vs topotecan in patients with advanced small cell lung cancer following 1st line chemotherapy | |
| Knight et al. | Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine | |
| JPWO2021062244A5 (cg-RX-API-DMAC7.html) | ||
| Seminario-Vidal et al. | 283 Toxic epidermal necrolysis in the setting of acute graft-versus-host disease successfully treated with tumor necrosis factor alpha inhibitors | |
| Vidal et al. | Legionella in a patient with rheumatoid arthritis receiving abatacept | |
| Yang et al. | Hepatic Arterial Infusion Chemotherapy combined with Tislelizumab and Donafenib induced Toxic Epidermal Necrolysis in a Primary Liver Carcinoma Patient-A case report | |
| HK40005970A (en) | Method of treating lower tract urothelial cancer | |
| BR122024005298A2 (pt) | Usos de antimetabólitos no tratamento de câncer urotelial do trato inferior, kits e dispositivo de liberação | |
| HK40044298A (en) | Microbiome related immunotherapies | |
| JPWO2021161032A5 (cg-RX-API-DMAC7.html) |